News
We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at ...
1h
Zacks Investment Research on MSNPfizer Stock Down Almost 11% YTD: Should You Buy the Dip?Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also ...
In the UK, anxiety, panic attacks and insomnia are not listed as possible side-effects for Ozempic, Wegovy or Mounjaro.
Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Village Health Workers in Zimbabwe use digital medical equipment and smartphones to diagnose and treat childhood ...
Bloomsbury is set to publish Bird Feeder by Hannah Lilly, a "deeply moving" memoir about how Lilly’s connection to the ...
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...
Since its launch in late March, Mounjaro sales have trebled. Winselow Tucker, president and general manager of Lilly in India ...
Eli Lilly & Co. sees 60% sales increase for weight-loss drug in India, tapping into growing demand for anti-obesity solutions ...
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results